ARENA PHARMACEUTICALS INC's ticker is and the CUSIP is 040047907. A total of 4 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,998,000 | +141.9% | 21,500 | +85.3% | 0.00% | +100.0% |
| Q3 2021 | $826,000 | +3.6% | 11,600 | -0.9% | 0.00% | 0.0% |
| Q2 2021 | $797,000 | +36.9% | 11,700 | +13828.6% | 0.00% | 0.0% |
| Q1 2021 | $582,000 | -35.8% | 84 | -28.8% | 0.00% | 0.0% |
| Q4 2020 | $906,000 | -71.3% | 118 | -72.0% | 0.00% | -75.0% |
| Q3 2020 | $3,156,000 | +812.1% | 422 | +667.3% | 0.00% | +300.0% |
| Q2 2020 | $346,000 | +9.8% | 55 | -26.7% | 0.00% | 0.0% |
| Q1 2020 | $315,000 | -4.8% | 75 | +2.7% | 0.00% | 0.0% |
| Q4 2019 | $331,000 | +64.7% | 73 | +65.9% | 0.00% | 0.0% |
| Q3 2019 | $201,000 | -36.4% | 44 | -18.5% | 0.00% | 0.0% |
| Q2 2019 | $316,000 | +47.0% | 54 | +12.5% | 0.00% | 0.0% |
| Q1 2019 | $215,000 | -30.9% | 48 | -40.0% | 0.00% | 0.0% |
| Q4 2018 | $311,000 | -30.3% | 80 | -17.5% | 0.00% | 0.0% |
| Q3 2018 | $446,000 | -18.2% | 97 | -22.4% | 0.00% | -50.0% |
| Q2 2018 | $545,000 | +32.3% | 125 | -74.8% | 0.00% | -88.9% |
| Q1 2018 | $412,000 | +8.4% | 496 | +5.1% | 0.02% | +12.5% |
| Q4 2017 | $380,000 | +113.5% | 472 | -32.4% | 0.02% | +128.6% |
| Q3 2017 | $178,000 | +150.7% | 698 | +162.4% | 0.01% | +133.3% |
| Q2 2017 | $71,000 | – | 266 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PURA VIDA INVESTMENTS, LLC | 291,100 | $27,055,000 | 0.98% |
| GROUP ONE TRADING, L.P. | 82,700 | $7,686,000 | 0.01% |
| SIMPLEX TRADING, LLC | 21,500 | $1,998,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |